Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak.
about
Prisoners co-infected with tuberculosis and HIV: a systematic reviewConfronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from MalaysiaTreatment Options for HIV-Associated Tuberculosis.Interaction studies of tipranavir-ritonavir with clarithromycin, fluconazole, and rifabutin in healthy volunteersRandomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapyRates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia.Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy.CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South IndiaNew approach for drug susceptibility testing: monitoring the stress response of mycobacteria.Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers.Prisons as a source of tuberculosis in Russia.Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.
P2860
Q28080180-AEA4E0C7-BB66-4576-923E-4A692EBD5E4EQ30250218-5A67BF18-C6BA-4717-BC7A-5502CE15068BQ33813097-844D06E4-584C-40FA-B4E5-7373EBCF3F1EQ34600493-8087FC06-3F1B-4C56-8B06-F8AB2DC22179Q34778531-9F22C8AB-5DFD-4759-BF86-91CC32F10287Q35537453-6DD7F7BE-1854-4BF9-A72F-EADB843D3FDCQ36235489-1FF26E05-D6E4-42F6-941F-ABAA46814BDEQ37115738-B10463E4-1199-42C9-95F9-055AFD02F486Q37409911-EAF18CF5-9694-4F81-BAD2-067D7CCE6EEDQ37734445-0F3265EB-729F-479B-A113-DE52A03DFFFFQ40770630-8F6C7B8F-F912-4D01-8B66-BF5CB7D55241Q45623559-D1B7792E-429A-46B8-9C34-50A34375B74E
P2860
Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Drug-drug interactions in inma ...... utional tuberculosis outbreak.
@en
Drug-drug interactions in inma ...... utional tuberculosis outbreak.
@nl
type
label
Drug-drug interactions in inma ...... utional tuberculosis outbreak.
@en
Drug-drug interactions in inma ...... utional tuberculosis outbreak.
@nl
prefLabel
Drug-drug interactions in inma ...... utional tuberculosis outbreak.
@en
Drug-drug interactions in inma ...... utional tuberculosis outbreak.
@nl
P2093
P2860
P356
P1476
Drug-drug interactions in inma ...... utional tuberculosis outbreak.
@en
P2093
Gallicano K
McLaughlin S
Peloquin CA
Spradling P
P2860
P304
P356
10.1086/343047
P407
P577
2002-10-10T00:00:00Z